D-0229-2026 Class II Ongoing
FDA drug recall D-0229-2026 was initiated by Novocol Pharmaceutical of Canada, Inc. on October 31, 2025 and is designated Class II. Reason for recall: Defective container: cracked/broken cartridges The recall status is ongoing. Affected quantity: 12,033 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- December 24, 2025
- Initiation Date
- October 31, 2025
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,033 cartons
Product Description
Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, MN55120, Manufactured by: Novocol Pharmaceutical of Canada, Inc., NDC 50227-1030-5.
Reason for Recall
Defective container: cracked/broken cartridges
Distribution Pattern
U.S.A. Nationwide
Code Information
Lot: D05362A, expires: 07-31-2027